MUC22
gene geneOn this page
Also known as PBMUCL1
Summary
MUC22 (mucin 22, HGNC:39755) is a protein-coding gene on chromosome 6p21.33, encoding Mucin-22 (E2RYF6).
Predicted to be located in membrane.
Source: NCBI Gene 100507679 — RefSeq curated summary.
At a glance
- GWAS associations: 56
- Clinical variants (ClinVar): 319 total
- MANE Select transcript:
NM_001395414
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:39755 |
| Approved symbol | MUC22 |
| Name | mucin 22 |
| Location | 6p21.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PBMUCL1 |
| Ensembl gene | ENSG00000261272 |
| Ensembl biotype | protein_coding |
| OMIM | 613917 |
| Entrez | 100507679 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000561890
RefSeq mRNA: 3 — MANE Select: NM_001395414
NM_001198815, NM_001318484, NM_001395414
CCDS: CCDS59003
Canonical transcript exons
ENST00000561890 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001748188 | 31032196 | 31032581 |
| ENSE00002595080 | 31010474 | 31010776 |
| ENSE00002609484 | 31025502 | 31030100 |
| ENSE00002613931 | 31034672 | 31035402 |
Expression profiles
Bgee: expression breadth broad, 19 present calls, max score 83.34.
Top tissues by expression
127 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.34 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 63.74 | gold quality |
| esophagus mucosa | UBERON:0002469 | 59.78 | gold quality |
| vagina | UBERON:0000996 | 48.26 | gold quality |
| esophagus | UBERON:0001043 | 43.79 | gold quality |
| tonsil | UBERON:0002372 | 41.26 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 40.87 | gold quality |
| granulocyte | CL:0000094 | 38.97 | gold quality |
| ganglionic eminence | UBERON:0004023 | 38.76 | gold quality |
| bone marrow cell | CL:0002092 | 38.11 | gold quality |
| apex of heart | UBERON:0002098 | 37.42 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| heart left ventricle | UBERON:0002084 | 36.75 | silver quality |
| muscle of leg | UBERON:0001383 | 36.72 | silver quality |
| muscle tissue | UBERON:0002385 | 36.57 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| gastrocnemius | UBERON:0001388 | 35.67 | silver quality |
| ectocervix | UBERON:0012249 | 35.17 | gold quality |
| sural nerve | UBERON:0015488 | 35.00 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 34.04 | gold quality |
| uterine cervix | UBERON:0000002 | 33.21 | gold quality |
| leukocyte | CL:0000738 | 32.98 | gold quality |
| monocyte | CL:0000576 | 32.82 | gold quality |
| bone marrow | UBERON:0002371 | 32.74 | gold quality |
| body of pancreas | UBERON:0001150 | 32.26 | gold quality |
| urinary bladder | UBERON:0001255 | 31.37 | gold quality |
| gall bladder | UBERON:0002110 | 30.75 | gold quality |
| liver | UBERON:0002107 | 30.31 | gold quality |
| prefrontal cortex | UBERON:0000451 | 30.06 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.16 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
35 targeting MUC22, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-29A-3P | 100.00 | 73.11 | 1835 |
| HSA-MIR-29B-3P | 100.00 | 73.18 | 1833 |
| HSA-MIR-29C-3P | 100.00 | 73.15 | 1833 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-433-3P | 99.98 | 69.37 | 1203 |
| HSA-MIR-767-5P | 99.95 | 70.85 | 993 |
| HSA-MIR-218-5P | 99.93 | 72.22 | 2103 |
| HSA-MIR-6768-5P | 99.92 | 67.36 | 1942 |
| HSA-MIR-5682 | 99.89 | 72.56 | 1005 |
| HSA-MIR-3140-3P | 99.88 | 68.47 | 2069 |
| HSA-MIR-944 | 99.82 | 70.85 | 3042 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-6887-3P | 99.66 | 67.83 | 1778 |
| HSA-MIR-516A-3P | 99.46 | 67.96 | 1378 |
| HSA-MIR-516B-3P | 99.46 | 67.96 | 1378 |
| HSA-MIR-7162-5P | 99.46 | 68.08 | 1368 |
| HSA-MIR-6731-5P | 99.28 | 67.42 | 2375 |
| HSA-MIR-8085 | 99.28 | 67.56 | 2362 |
| HSA-MIR-4279 | 99.19 | 66.70 | 2437 |
| HSA-MIR-544B | 99.18 | 67.41 | 1632 |
| HSA-MIR-6871-5P | 98.90 | 66.67 | 671 |
| HSA-MIR-4725-5P | 98.67 | 65.42 | 628 |
| HSA-MIR-504-5P | 98.67 | 65.40 | 631 |
| HSA-MIR-6804-5P | 98.39 | 65.77 | 1084 |
| HSA-MIR-219B-5P | 97.91 | 65.80 | 531 |
| HSA-MIR-30C-1-3P | 97.80 | 66.36 | 1499 |
Literature-anchored findings (GeneRIF, showing 4)
- The mucin-like gene PBMUCL1 is also one of the candidate genes of Diffuse panbronchiolitis susceptibility. (PMID:20981447)
- Genes TGFB1, TLE4 and MUC22 are associated with the risk of childhood asthma in Chinese population. (PMID:28262390)
- Differential MUC22 expression by epigenetic alterations in human lung squamous cell carcinoma and adenocarcinoma. (PMID:33786615)
- MUC22, HLA-A, and HLA-DOB variants and COVID-19 in resilient super-agers from Brazil. (PMID:36389712)
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Mucin-22 — E2RYF6 (reviewed: E2RYF6)
Alternative names: Panbronchiolitis-related mucin-like protein 1
All UniProt accessions (1): E2RYF6
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Tissue specificity. Expressed in lung by serous cells of the submucosal gland (at protein level). Detected in the placenta, lung and testis.
Induction. Up-regulated by poly(I:C).
RefSeq proteins (3): NP_001185744, NP_001305413, NP_001382343* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR028199 | Mucin_dom | Domain |
| IPR053330 | Mucin-22-like | Family |
Pfam: PF14654
UniProt features (26 total): compositionally biased region 10, region of interest 9, topological domain 2, signal peptide 1, chain 1, sequence variant 1, sequence conflict 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-E2RYF6-F1 | 67.14 | 0.04 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 20 (showing top):
ID1_TARGET_GENES, MIR4262, MIR181A_5P_MIR181B_5P, MIR181D_5P, MIR181C_5P, MIR29B_3P_MIR29C_3P, MIR29A_3P, MIR8085, MIR6731_5P, MIR1291, MIR6775_3P, SMN1_SMN2_TARGET_GENES, DESCARTES_MAIN_FETAL_CORNEAL_AND_CONJUNCTIVAL_EPITHELIAL_CELLS, DESCARTES_FETAL_LUNG_SQUAMOUS_EPITHELIAL_CELLS, NABA_ECM_AFFILIATED
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
320 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MUC22 | MUC12 | Q9UKN1 | 737 |
| MUC22 | MUC4 | Q99102 | 701 |
| MUC22 | MUC20 | Q8N307 | 696 |
| MUC22 | MUC15 | Q8N387 | 696 |
| MUC22 | MUC19 | Q7Z5P9 | 667 |
| MUC22 | MUC7 | Q8TAX7 | 659 |
| MUC22 | MUC13 | Q9H3R2 | 645 |
| MUC22 | MUC3A | Q02505 | 624 |
| MUC22 | MUC1 | P13931 | 596 |
| MUC22 | MUC17 | Q685J3 | 594 |
| MUC22 | MUC5B | Q9HC84 | 573 |
| MUC22 | MUC6 | Q6W4X9 | 556 |
| MUC22 | MUC16 | Q8WXI7 | 540 |
| MUC22 | CCHCR1 | Q8TD31 | 534 |
| MUC22 | MUC5AC | P98088 | 532 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KLHL22 | TRAV18 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (1): MUC22 (Affinity Capture-MS)
ESM2 similar proteins: A0A023PXQ4, A0A0U1RQI7, A6NJU9, A6NNC1, A8MRT5, A8MUU9, C9JG80, E2RYF6, E5RHQ5, F8W0I5, O13534, O59779, P08399, P0C732, P0C785, P0DTH6, P0DW28, P13208, P15941, P21787, P24856, P39564, P51861, P87269, Q00130, Q01456, Q12444, Q13117, Q1HVI8, Q27905, Q2EEQ3, Q4ZJY7, Q4ZJZ0, Q5SDL7, Q63661, Q69577, Q6B0Y1, Q6RY98, Q6ZQT0, Q6ZRX8
Diamond homologs: E2RYF6, Q5SSG8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
319 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 264 |
| Likely benign | 48 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
522 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:31010777:G:GG | donor_gain | 1.0000 |
| 6:31024289:GGATC:G | donor_gain | 0.9900 |
| 6:31034670:A:AG | acceptor_gain | 0.9900 |
| 6:31034671:G:GG | acceptor_gain | 0.9900 |
| 6:31010774:CCA:C | donor_gain | 0.9800 |
| 6:31010775:CA:C | donor_gain | 0.9800 |
| 6:31034671:GA:G | acceptor_gain | 0.9800 |
| 6:31010772:ACCCA:A | donor_gain | 0.9700 |
| 6:31010773:CCCA:C | donor_gain | 0.9700 |
| 6:31010773:CCCAG:C | donor_loss | 0.9700 |
| 6:31010774:CCAG:C | donor_loss | 0.9700 |
| 6:31010775:CAG:C | donor_loss | 0.9700 |
| 6:31010776:AG:A | donor_loss | 0.9700 |
| 6:31010778:TAAG:T | donor_loss | 0.9700 |
| 6:31010779:AAGT:A | donor_loss | 0.9700 |
| 6:31029966:GCTC:G | donor_gain | 0.9700 |
| 6:31032417:G:GT | donor_gain | 0.9700 |
| 6:31032565:GAC:G | donor_gain | 0.9700 |
| 6:31034671:GAGA:G | acceptor_gain | 0.9700 |
| 6:31034671:GAGAA:G | acceptor_gain | 0.9700 |
| 6:31034719:T:TA | acceptor_gain | 0.9700 |
| 6:31024306:G:GA | donor_gain | 0.9600 |
| 6:31032418:A:T | donor_gain | 0.9600 |
| 6:31034666:TTTTA:T | acceptor_loss | 0.9600 |
| 6:31034670:A:AC | acceptor_loss | 0.9600 |
| 6:31034671:G:GA | acceptor_loss | 0.9600 |
| 6:31024305:T:TA | donor_gain | 0.9500 |
| 6:31025496:C:G | acceptor_gain | 0.9500 |
| 6:31030097:TCAG:T | donor_loss | 0.9500 |
| 6:31030098:CAGG:C | donor_loss | 0.9500 |
AlphaMissense
11122 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:31032552:G:A | G1676R | 0.961 |
| 6:31032552:G:C | G1676R | 0.961 |
| 6:31032507:T:A | W1661R | 0.927 |
| 6:31032507:T:C | W1661R | 0.927 |
| 6:31032535:C:A | A1670E | 0.926 |
| 6:31032544:C:A | A1673D | 0.924 |
| 6:31032553:G:A | G1676E | 0.922 |
| 6:31032564:G:A | G1680R | 0.921 |
| 6:31032564:G:C | G1680R | 0.921 |
| 6:31032532:C:A | A1669D | 0.908 |
| 6:31032547:C:A | A1674D | 0.898 |
| 6:31032534:G:C | A1670P | 0.896 |
| 6:31032509:G:C | W1661C | 0.891 |
| 6:31032509:G:T | W1661C | 0.891 |
| 6:31032550:T:A | V1675D | 0.889 |
| 6:31032538:T:A | V1671D | 0.883 |
| 6:31032529:T:C | L1668P | 0.873 |
| 6:31032529:T:G | L1668R | 0.868 |
| 6:31032565:G:A | G1680E | 0.865 |
| 6:31032573:T:C | F1683L | 0.857 |
| 6:31032575:T:A | F1683L | 0.857 |
| 6:31032575:T:G | F1683L | 0.857 |
| 6:31032543:G:C | A1673P | 0.834 |
| 6:31032570:A:C | S1682R | 0.833 |
| 6:31032572:T:A | S1682R | 0.833 |
| 6:31032572:T:G | S1682R | 0.833 |
| 6:31032541:T:A | V1672E | 0.826 |
| 6:31032546:G:C | A1674P | 0.826 |
| 6:31034843:T:C | F1743L | 0.802 |
| 6:31034845:T:A | F1743L | 0.802 |
dbSNP variants (sampled 300 via entrez): RS1000069205 (6:31012720 C>T), RS1000099448 (6:31021928 T>A,C,G), RS1000175654 (6:30989774 T>C), RS1000334988 (6:31017458 A>C), RS1000463453 (6:31021239 C>G), RS1000619275 (6:31030033 C>G,T), RS1000695625 (6:31023120 A>C), RS1000723137 (6:31020624 C>G,T), RS1000766113 (6:31024810 T>C), RS1001062150 (6:31012409 G>A,C), RS1001091231 (6:30996327 C>T), RS1001103207 (6:31028562 C>A), RS1001248730 (6:30991531 G>C), RS1001284461 (6:31005868 G>C), RS1001355253 (6:31006171 A>C)
Disease associations
OMIM: gene MIM:613917 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
56 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002837_1 | Change in intraocular pressure in response to steroid treatment (triamcinolone acetonide) | 5.000000e-09 |
| GCST003123_16 | Severe influenza A (H1N1) infection | 2.000000e-14 |
| GCST004521_114 | Autism spectrum disorder or schizophrenia | 3.000000e-17 |
| GCST004521_117 | Autism spectrum disorder or schizophrenia | 3.000000e-15 |
| GCST004521_132 | Autism spectrum disorder or schizophrenia | 2.000000e-09 |
| GCST004521_171 | Autism spectrum disorder or schizophrenia | 4.000000e-14 |
| GCST004521_19 | Autism spectrum disorder or schizophrenia | 2.000000e-12 |
| GCST004521_2 | Autism spectrum disorder or schizophrenia | 2.000000e-16 |
| GCST004521_209 | Autism spectrum disorder or schizophrenia | 5.000000e-16 |
| GCST004521_210 | Autism spectrum disorder or schizophrenia | 5.000000e-15 |
| GCST004521_211 | Autism spectrum disorder or schizophrenia | 5.000000e-15 |
| GCST004521_229 | Autism spectrum disorder or schizophrenia | 4.000000e-11 |
| GCST004521_257 | Autism spectrum disorder or schizophrenia | 6.000000e-10 |
| GCST004521_265 | Autism spectrum disorder or schizophrenia | 7.000000e-14 |
| GCST004521_27 | Autism spectrum disorder or schizophrenia | 1.000000e-09 |
| GCST004521_282 | Autism spectrum disorder or schizophrenia | 5.000000e-09 |
| GCST004521_295 | Autism spectrum disorder or schizophrenia | 6.000000e-18 |
| GCST004521_3 | Autism spectrum disorder or schizophrenia | 2.000000e-15 |
| GCST004521_48 | Autism spectrum disorder or schizophrenia | 1.000000e-09 |
| GCST004521_70 | Autism spectrum disorder or schizophrenia | 8.000000e-20 |
| GCST004748_105 | Lung cancer | 3.000000e-17 |
| GCST004750_54 | Squamous cell lung carcinoma | 6.000000e-16 |
| GCST008163_465 | Height | 4.000000e-07 |
| GCST008386_1 | Carbamazepine-induced serious cutaneous adverse reaction | 2.000000e-06 |
| GCST010002_46 | Refractive error | 2.000000e-20 |
| GCST010725_70 | Malaria | 5.000000e-06 |
| GCST010725_9 | Malaria | 6.000000e-06 |
| GCST010867_62 | Coronary artery disease | 1.000000e-18 |
| GCST011938_7 | Takayasu arteritis | 5.000000e-31 |
| GCST012194_4 | Obsessive-compulsive traits | 5.000000e-06 |
EFO canonical traits (6, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006956 | intraocular pressure change measurement |
| EFO:1001488 | influenza A (H1N1) |
| EFO:0008039 | BMI-adjusted hip circumference |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0007874 | gut microbiome measurement |
| EFO:0007789 | BMI-adjusted waist circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | decreases expression | 1 |
| tetrabromobisphenol A | increases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| clothianidin | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): severe cutaneous adverse reaction, Takayasu arteritis